MENU
SRS.ORG
SRS
September 2016

Nominating Committee

John P. Dormans, MD, FACS
Nominating Committee Chair

The nomination period was from December 1, 2015, to March 1, 2016. All SRS members were invited to nominate members for the following positions: Vice-President, three Directors At-Large for the Board of Directors, and a Fellowship Committee member. We received an outstanding number of nominations for these positions and the Committee has subsequently reviewed and considered the large list of qualified candidates.

All potential candidates were contacted by the Committee Chair to clarify the position duties and to confirm the candidates’ commitment to serve. The final nomination list has been completed and presented to the Board of Directors, for information only, at the IMAST meeting in Washington, D.C., United States in July 2016. The nominees will then be voted upon at the first membership business meeting in September during the 51st Annual Meeting & Course in Prague, Czech Republic.

A proposed list of changes for the nominating process for Board of Directors at-large members has been created. The proposed changes are as follows:

  • All nominees must be Active Fellows in good standing.
  • Nominees for all positions should regularly attend the Annual Meeting & Course and/or IMAST, and should actively participate in and/or contribute to other SRS activities such as research grant applications, endowment contributions, outreach programs, submission or presentation of papers, serving as faculty for courses, participation in committees, submission of M&M data, etc.
  • Nominees for the position of Director at Large should have chaired at least one SRS Committee.
  • At the Nominating Committee’s discretion, those being considered for this position, who are from outside North America or who are ≤45 years old, may qualify with active service on at least four committees, of which a minimum of two were as an Active Fellow.
  • Nominees for the position of Vice President, Secretary-Elect or Treasurer-Elect should have served either as a Director at Large or as a Council Chair.

Chair: John P. Dormans, MD, FACS Committee: Marinus de Kleuver, MD, PhD; John R. Dimar, MD; Kamal N. Ibrahim, MD; B. Stephens Richards, III, MD.